The SAS "Special Access Scheme" for the Australian market is interesting. I don't fully understand why, if you can access Oncosil through the SAS even if you cannot advertise it, it would not have TGA approval in Australia. Does anyone know how to better explain it? Can anyone enlighten me?
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
99.0¢ |
Change
0.020(2.06%) |
Mkt cap ! $13.79M | |||
| Open | High | Low | Value | Volume |
| 99.5¢ | 99.5¢ | 99.0¢ | $3.074K | 3.105K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 3907 | 97.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 99.5¢ | 3684 | 2 |
View Market Depth
| Last trade - 09.59am 24/06/2025 (20 minute delay) ? |
| OSL (ASX) Chart |